Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1986 May;144(5):559–563.

Evidence for Environmental Familiality of Kallikrein Excretion in Utah Kindreds

Mary M Dadone 1,2,3,4, Roger R Williams 1,2,3,4, K Owen Ash 1,2,3,4, Jean B Smith 1,2,3,4, Douglas L Anderton 1,2,3,4
PMCID: PMC1306703  PMID: 3636040

Abstract

In investigating the role of urinary kallikrein in the pathophysiology of hypertension, we measured 12-hour kallikrein excretion in 1,100 persons in 68 Utah kindreds. The kallikrein excretion was statistically adjusted to account for variations in body size and urine output.

Adjusted kallikrein excretion was greater in youths than in adults and correlated with potassium excretion and sodium excretion in persons with normal blood pressure. It was decreased in normotensive subjects with strong family histories of stroke and hypertension, but was not significantly different in adults with hypertension.

Adjusted kallikrein excretion was correlated between pairs of siblings, parent-offspring pairs and spouses. Our results indicate that kallikrein excretion is a familial variable, with the familiality due more to shared environmental than genetic factors.

Full text

PDF
559

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe K., Yasujima M., Irokawa N., Seino M., Chiba S., Sakurai Y., Sato M., Imai Y., Saito K., Ito T. The role of intrarenal vasoactive substances in the pathogenesis of essential hypertension. Clin Sci Mol Med Suppl. 1978 Dec;4:363s–366s. doi: 10.1042/cs055363s. [DOI] [PubMed] [Google Scholar]
  2. Adetuyibi A., Mills I. H. Relation between urinary kallikrein and renal function, hypertension, and excretion of sodium and water in man. Lancet. 1972 Jul 29;2(7770):203–207. doi: 10.1016/s0140-6736(72)91636-4. [DOI] [PubMed] [Google Scholar]
  3. Ash K. O., Smith J. B., Lynch M., Dadone M., Tolman K. G., Williams R. R. Urinary kallikrein: assay validation and physiological variability. Clin Chim Acta. 1985 Sep 30;151(2):133–140. doi: 10.1016/0009-8981(85)90316-x. [DOI] [PubMed] [Google Scholar]
  4. Beaven V. H., Pierce J. V., Pisano J. J. A sensitive isotopic procedure for the assay of esterase activity: measurement of human urinary kallikrein. Clin Chim Acta. 1971 Mar;32(1):67–73. doi: 10.1016/0009-8981(71)90465-7. [DOI] [PubMed] [Google Scholar]
  5. Bruhn H. D., Brück M., Albert J. P. Plasma prekallikrein in hypertension. Acta Chir Scand Suppl. 1982;509:133–135. [PubMed] [Google Scholar]
  6. Godard C., Vallotton M. B., Favre L. Urinary prostaglandins, vasopressin, and kallikrein excretion in healthy children from birth to adolescence. J Pediatr. 1982 Jun;100(6):898–902. doi: 10.1016/s0022-3476(82)80508-8. [DOI] [PubMed] [Google Scholar]
  7. Green G. D., Shaw E. Thiobenzyl benzyloxycarbonyl-L-lysinate, substrate for a sensitive colorimetric assay for trypsin-like enzymes. Anal Biochem. 1979 Mar;93(2):223–226. doi: 10.1016/s0003-2697(79)80141-4. [DOI] [PubMed] [Google Scholar]
  8. Hohn A. R., Riopel D. A., Keil J. E., Loadholt C. B., Margolius H. S., Halushka P. V., Privitera P. J., Webb J. G., Medley E. S., Schuman S. H. Childhood familial and racial differences in physiologic and biochemical factors related to hypertension. Hypertension. 1983 Jan-Feb;5(1):56–70. doi: 10.1161/01.hyp.5.1.56. [DOI] [PubMed] [Google Scholar]
  9. Holland O. B., Chud J. M., Braunstein H. Urinary kallikrein excretion in essential and mineralocorticoid hypertension. J Clin Invest. 1980 Feb;65(2):347–356. doi: 10.1172/JCI109678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Horwitz D., Margolius H. S., Keiser H. R. Effects of dietary potassium and race on urinary excretion of kallikrein and aldosterone in man. J Clin Endocrinol Metab. 1978 Aug;47(2):296–299. doi: 10.1210/jcem-47-2-296. [DOI] [PubMed] [Google Scholar]
  11. Lawton W. J., Fitz A. E. Urinary kallikrein in normal renin essential hypertension. Circulation. 1977 Nov;56(5):856–859. doi: 10.1161/01.cir.56.5.856. [DOI] [PubMed] [Google Scholar]
  12. Levinsky N. G. The renal kallikrein-kinin system. Circ Res. 1979 Apr;44(4):441–451. doi: 10.1161/01.res.44.4.441. [DOI] [PubMed] [Google Scholar]
  13. Levy S. B., Lilley J. J., Frigon R. P., Stone R. A. Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake. J Clin Invest. 1977 Jul;60(1):129–138. doi: 10.1172/JCI108749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lieberthal W., Arbeit L., Oza N. B., Bernard D. B., Levinsky N. G. Reduced ratio of active-to-total urinary kallikrein in essential hypertension. Hypertension. 1983 Jul-Aug;5(4):603–609. doi: 10.1161/01.hyp.5.4.603. [DOI] [PubMed] [Google Scholar]
  15. Margolis H. S., Geller R., Pisano J. J., Sjoerdsma A. Altered urinary kallikrein excretion in human hypertension. Lancet. 1971 Nov 13;2(7733):1063–1065. doi: 10.1016/s0140-6736(71)90382-5. [DOI] [PubMed] [Google Scholar]
  16. Margolius H. S., Horwitz D., Geller R. G., Alexander R. W., Gill J. R., Jr, Pisano J. J., Keiser H. R. Urinary kallikrein excretion in normal man. Relationships to sodium intake and sodium-retaining steroids. Circ Res. 1974 Dec;35(6):812–819. doi: 10.1161/01.res.35.6.812. [DOI] [PubMed] [Google Scholar]
  17. Margolius H. S., Horwitz D., Pisano J. J., Keiser H. R. Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids. Circ Res. 1974 Dec;35(6):820–825. doi: 10.1161/01.res.35.6.820. [DOI] [PubMed] [Google Scholar]
  18. O'Connor D. T., Preston R. A., Mitas J. A., 2nd, Frigon R. P., Stone R. A. Urinary kallikrein activity and renal vascular resistance in the antihypertensive response to thiazide diuretics. Hypertension. 1981 Jan-Feb;3(1):139–147. doi: 10.1161/01.hyp.3.1.139. [DOI] [PubMed] [Google Scholar]
  19. Ura N., Shimamoto K., Nakao T., Ogasawara A., Tanaka S., Mita T., Nishimiya T., Iimura O. The excretion of human urinary kallikrein quantity and activity in normal and low renin subgroups of essential hypertension. Clin Exp Hypertens A. 1983;5(3):329–337. doi: 10.3109/10641968309069492. [DOI] [PubMed] [Google Scholar]
  20. Vinci J. M., Zusman R. M., Izzo J. L., Jr, Bowden R. E., Horwitz D., Pisano J. J., Keiser H. R. Human urinary and plasma kinins: relationship to sodium-retaining steroids and plasma renin activity. Circ Res. 1979 Feb;44(2):228–237. doi: 10.1161/01.res.44.2.228. [DOI] [PubMed] [Google Scholar]
  21. Zinner S. H., Margolius H. S., Rosner B., Kass E. H. Stability of blood pressure rank and urinary kallikrein concentration in childhood: an eight-year follow-up. Circulation. 1978 Nov;58(5):908–915. doi: 10.1161/01.cir.58.5.908. [DOI] [PubMed] [Google Scholar]
  22. Zinner S. H., Margolius H. S., Rosner B., Keiser H. R., Kass E. H. Familial aggregation of urinary kallikrein concentration in childhood: relation to blood pressure, race and urinary electrolytes. Am J Epidemiol. 1976 Aug;104(2):124–132. doi: 10.1093/oxfordjournals.aje.a112282. [DOI] [PubMed] [Google Scholar]
  23. Zschiedrich H., Fleckenstein P., Geiger R., Fink E., Sinterhauf K., Philipp T., Distler A., Wolff H. P. Urinary kallikrein in normotensive subjects and in patients with essential hypertension. Clin Exp Hypertens. 1980;2(3-4):693–708. doi: 10.3109/10641968009037137. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES